{
    "Trade/Device Name(s)": [
        "Anti RNA Polymerase III ELISA Kit",
        "MBL Anti-RNA Polymerase III ELISA Kit"
    ],
    "Submitter Information": "MBL International Corporation",
    "510(k) Number": "K060431",
    "Predicate Device Reference 510(k) Number(s)": [
        "K040200",
        "K972145"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NYO"
    ],
    "Summary Letter Date": "June 19, 2006",
    "Summary Letter Received Date": "February 27, 2006",
    "Submission Date": "February 16, 2006",
    "Regulation Number(s)": [
        "21 CFR 866.5100"
    ],
    "Regulation Name(s)": [
        "Antinuclear antibody immunological system"
    ],
    "Analyte Class(es)": [
        "autoimmune",
        "immunology"
    ],
    "Analyte(s)": [
        "Anti-RNA Polymerase III antibody"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Enzyme-linked immunosorbent assay (ELISA)"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for MBL Anti-RNA Polymerase III ELISA Kit detecting anti-RNA Polymerase III antibodies for aiding diagnosis of systemic sclerosis",
    "Indications for Use Summary": "A semi-quantitative ELISA for detection of anti-RNA Polymerase III antibodies in human serum to aid diagnosis of systemic sclerosis (SSc), for in-vitro diagnostic use",
    "fda_folder": "Immunology"
}